Significant increases in the levels of liver enzymes in mice treated with anti-tuberculosis drugs
Authors:
- Anne J. LenaertsALAnne J. Lenaerts
- Christine M. JohnsonCJChristine M. Johnson
- Karen S. MarrietaKMKaren S. Marrieta
- Veronica GruppoVGVeronica Gruppo
- Ian M. OrmeIOIan M. Orme
- 1 August 2005
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 26 (2) , 152-158
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Recent developments in the treatment of tuberculosisExpert Opinion on Investigational Drugs, 2003
- Rapid In Vivo Screening of Experimental Drugs for Tuberculosis Using Gamma Interferon Gene-Disrupted MiceAntimicrobial Agents and Chemotherapy, 2003
- Targeted Tuberculin Testing and Treatment of Latent Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Activities of Several Novel Oxazolidinones against Mycobacterium tuberculosis in a Murine ModelAntimicrobial Agents and Chemotherapy, 1999
- In Vitro and In Vivo Activities of Moxifloxacin and Clinafloxacin against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1998
- Hepatotoxicity in drug development: detection, significance and solutionsJournal of Hepatology, 1997
- In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1995
- Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine modelAntimicrobial Agents and Chemotherapy, 1994
- Activity of levofloxacin in a murine model of tuberculosisAntimicrobial Agents and Chemotherapy, 1994
- Long-term, two-stage chemotherpay of advanced experimental murine tuberculosis with intermittent regimes during the second stageTubercle, 1963